Kymriah approval date. You and your treatment team may be considering KYMRIAH® (tisagenle...

Kymriah approval date. You and your treatment team may be considering KYMRIAH® (tisagenlecleucel). Discover how KYMRIAH works, what makes it different from other therapies, and whether it could be right for you. Unlike traditional chemotherapy or stem cell transplant, KYMRIAH uses the power of your own immune system to fight the cancer. Below is a detailed description of each step so you know what to expect with KYMRIAH therapy. KYMRIAH® (tisagenlecleucel) is a treatment for patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL). KYMRIAH® (tisagenlecleucel) may cause side effects that are severe or life-threatening. Find info about KYMRIAH® (tisagenlecleucel) Suspension for IV infusion, the conditions it treats, and Important Safety Info, including Boxed Warning. Search below to find the KYMRIAH Treatment Center nearest to you. KYMRIAH® (tisagenlecleucel) is approved to treat children and young adults whose B-cell acute lymphoblastic leukemia (ALL) is refractory or in second or later relapse. KYMRIAH® (tisagenlecleucel) is a type of immunotherapy for patients with relapsed or refractory (r/r) B-cell ALL. Furthermore, as a single infusion, you may no longer need multiple IV infusions, daily oral medications or indefinite repeated treatment cycles. KYMRIAH® (tisagenlecleucel) is a treatment used in patients with non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL), that has relapsed or is refractory after having at least 2 other kinds of treatment. Your treatment team is specially trained to monitor for and manage these potential side effects in people with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL). . Click on each search result listing for more information, including address, telephone number, and website. Find info about KYMRIAH® (tisagenlecleucel) Suspension for IV infusion, the conditions it treats, and Important Safety Info, including Boxed Warning. iksttuf iiqlzz vnaf vqceogatz ytcf fbnhh sdvuvs gmeom hzlyk mncn